3PP0 - Sequence, Chains, Asymmetric and Biological Units

• Title: CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN HER2 (ERBB2)
• Keywords: KINASE DOMAIN, ANTI-ONCOGENE, ATP-BINDING, CELL CYCLE, DISEA MUTATION, GLYCOPROTEIN, MEMBRANE, NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, RECEPTOR, SECRETED, TRANSFERASE, TRANSMEMBR TYROSINE-PROTEIN KINASE, TYROSINE KINASE INHIBITOR, TRANSFE TRANSFERASE INHIBITOR COMPLEX
• Experiment: X-ray diffraction
• Number of Models: 1

Database	ID code	Status	Coordinate files
			Header	Asymmetric unit	Biological unit
PDB	3PP0	released	available	available	Quaternary Structure Server

Asymmetric unit from PDB

Unit	Type	Name	Chain ID	Residues	Atoms	Hetatoms
1	Protein	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2	A	286	2287	0
2	Protein	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2	B	296	2370	0
3	Ligand	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2	A	1	0	34
4	Ligand	RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2	B	1	0	34
5	Water			190	0	190
total				774	4657	258

Proteins

Unit 1

ALA 706 PRO 707 ASN 708 GLN 709 ALA 710 LEU 711 LEU 712 ARG 713 ILE 714 LEU 715 LYS 716 GLU 717 THR 718 GLU 719 LEU 720 ARG 721 LYS 722 VAL 723 LYS 724 VAL 725 LEU 726 GLY 727 SER 728 GLY 729 ALA 730 PHE 731 GLY 732 THR 733 VAL 734 TYR 735 LYS 736 GLY 737 ILE 738 TRP 739 ILE 740 PRO 741 ASP 742 GLY 743 GLU 744 ASN 745 VAL 746 LYS 747 ILE 748 PRO 749 VAL 750 ALA 751 ILE 752 LYS 753 VAL 754 LEU 755 ARG 756 GLU 757 ASN 758 THR 759 SER 760 PRO 761 LYS 762 ALA 763 ASN 764 LYS 765 GLU 766 ILE 767 LEU 768 ASP 769 GLU 770 ALA 771 TYR 772 VAL 773 MET 774 ALA 775 GLY 776 VAL 777 GLY 778 SER 779 PRO 780 TYR 781 VAL 782 SER 783 ARG 784 LEU 785 LEU 786 GLY 787 ILE 788 CYS 789 LEU 790 THR 791 SER 792 THR 793 VAL 794 GLN 795 LEU 796 VAL 797 THR 798 GLN 799 LEU 800 MET 801 PRO 802 TYR 803 GLY 804 CYS 805 LEU 806 LEU 807 ASP 808 HIS 809 VAL 810 ARG 811 GLU 812 ASN 813 ARG 814 GLY 815 ARG 816 LEU 817 GLY 818 SER 819 GLN 820 ASP 821 LEU 822 LEU 823 ASN 824 TRP 825 CYS 826 MET 827 GLN 828 ILE 829 ALA 830 LYS 831 GLY 832 MET 833 SER 834 TYR 835 LEU 836 GLU 837 ASP 838 VAL 839 ARG 840 LEU 841 VAL 842 HIS 843 ARG 844 ASP 845 LEU 846 ALA 847 ALA 848 ARG 849 ASN 850 VAL 851 LEU 852 VAL 853 LYS 854 SER 855 PRO 856 ASN 857 HIS 858 VAL 859 LYS 860 ILE 861 THR 862 ASP 863 PHE 864 GLY 865 LEU 866 ALA 867 ARG 868 LEU 869 LEU 870 ASP 871 ILE 872 ASP 873 GLU 874 THR 875 GLU 876 TYR 877 HIS 878 ALA 879 GLY 882 LYS 883 VAL 884 PRO 885 ILE 886 LYS 887 TRP 888 MET 889 ALA 890 LEU 891 GLU 892 SER 893 ILE 894 LEU 895 ARG 896 ARG 897 ARG 898 PHE 899 THR 900 HIS 901 GLN 902 SER 903 ASP 904 VAL 905 TRP 906 SER 907 TYR 908 GLY 909 VAL 910 THR 911 VAL 912 TRP 913 GLU 914 LEU 915 MET 916 THR 917 PHE 918 GLY 919 ALA 920 LYS 921 PRO 922 TYR 923 ASP 924 GLY 925 ILE 926 PRO 927 ALA 928 ARG 929 GLU 930 ILE 931 PRO 932 ASP 933 LEU 934 LEU 935 GLU 936 LYS 937 GLY 938 GLU 939 ARG 940 LEU 941 PRO 942 GLN 943 PRO 944 PRO 945 ILE 946 CYS 947 THR 948 ILE 949 ASP 950 VAL 951 TYR 952 MET 953 ILE 954 MET 955 VAL 956 LYS 957 CYS 958 TRP 959 MET 960 ILE 961 ASP 962 SER 963 GLU 964 CYS 965 ARG 966 PRO 967 ARG 968 PHE 969 ARG 970 GLU 971 LEU 972 VAL 973 SER 974 GLU 975 PHE 976 SER 977 ARG 978 MET 979 ALA 980 ARG 981 ASP 982 PRO 983 GLN 984 ARG 985 PHE 986 VAL 987 VAL 988 ILE 989 GLN 990 ASN 991 GLU 992 ASP 993

Unit 2

ALA 706 PRO 707 ASN 708 GLN 709 ALA 710 LEU 711 LEU 712 ARG 713 ILE 714 LEU 715 LYS 716 GLU 717 THR 718 GLU 719 LEU 720 ARG 721 LYS 722 VAL 723 LYS 724 VAL 725 LEU 726 GLY 727 SER 728 GLY 729 ALA 730 PHE 731 GLY 732 THR 733 VAL 734 TYR 735 LYS 736 GLY 737 ILE 738 TRP 739 ILE 740 PRO 741 ASP 742 GLY 743 GLU 744 ASN 745 VAL 746 LYS 747 ILE 748 PRO 749 VAL 750 ALA 751 ILE 752 LYS 753 VAL 754 LEU 755 ARG 756 GLU 757 ASN 758 THR 759 SER 760 PRO 761 LYS 762 ALA 763 ASN 764 LYS 765 GLU 766 ILE 767 LEU 768 ASP 769 GLU 770 ALA 771 TYR 772 VAL 773 MET 774 ALA 775 GLY 776 VAL 777 GLY 778 SER 779 PRO 780 TYR 781 VAL 782 SER 783 ARG 784 LEU 785 LEU 786 GLY 787 ILE 788 CYS 789 LEU 790 THR 791 SER 792 THR 793 VAL 794 GLN 795 LEU 796 VAL 797 THR 798 GLN 799 LEU 800 MET 801 PRO 802 TYR 803 GLY 804 CYS 805 LEU 806 LEU 807 ASP 808 HIS 809 VAL 810 ARG 811 GLU 812 ASN 813 ARG 814 GLY 815 ARG 816 LEU 817 GLY 818 SER 819 GLN 820 ASP 821 LEU 822 LEU 823 ASN 824 TRP 825 CYS 826 MET 827 GLN 828 ILE 829 ALA 830 LYS 831 GLY 832 MET 833 SER 834 TYR 835 LEU 836 GLU 837 ASP 838 VAL 839 ARG 840 LEU 841 VAL 842 HIS 843 ARG 844 ASP 845 LEU 846 ALA 847 ALA 848 ARG 849 ASN 850 VAL 851 LEU 852 VAL 853 LYS 854 SER 855 PRO 856 ASN 857 HIS 858 VAL 859 LYS 860 ILE 861 THR 862 ASP 863 PHE 864 GLY 865 LEU 866 ALA 867 ARG 868 LEU 869 LEU 870 ASP 871 ILE 872 ASP 873 GLU 874 THR 875 GLU 876 TYR 877 HIS 878 ALA 879 GLY 882 LYS 883 VAL 884 PRO 885 ILE 886 LYS 887 TRP 888 MET 889 ALA 890 LEU 891 GLU 892 SER 893 ILE 894 LEU 895 ARG 896 ARG 897 ARG 898 PHE 899 THR 900 HIS 901 GLN 902 SER 903 ASP 904 VAL 905 TRP 906 SER 907 TYR 908 GLY 909 VAL 910 THR 911 VAL 912 TRP 913 GLU 914 LEU 915 MET 916 THR 917 PHE 918 GLY 919 ALA 920 LYS 921 PRO 922 TYR 923 ASP 924 GLY 925 ILE 926 PRO 927 ALA 928 ARG 929 GLU 930 ILE 931 PRO 932 ASP 933 LEU 934 LEU 935 GLU 936 LYS 937 GLY 938 GLU 939 ARG 940 LEU 941 PRO 942 GLN 943 PRO 944 PRO 945 ILE 946 CYS 947 THR 948 ILE 949 ASP 950 VAL 951 TYR 952 MET 953 ILE 954 MET 955 VAL 956 LYS 957 CYS 958 TRP 959 MET 960 ILE 961 ASP 962 SER 963 GLU 964 CYS 965 ARG 966 PRO 967 ARG 968 PHE 969 ARG 970 GLU 971 LEU 972 VAL 973 SER 974 GLU 975 PHE 976 SER 977 ARG 978 MET 979 ALA 980 ARG 981 ASP 982 PRO 983 GLN 984 ARG 985 PHE 986 VAL 987 VAL 988 ILE 989 GLN 990 ASN 991 GLU 992 PRO 999 LEU 1000 ASP 1001 SER 1002 THR 1003 PHE 1004 TYR 1005 ARG 1006 SER 1007 LEU 1008 LEU 1009

Ligands

Unit 3	03Q 1
Unit 4	03Q 2